Literature DB >> 20848547

Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study.

Toshiaki Watanabe1, Tsuyoshi Konishi, Junji Kishimoto, Kenjiro Kotake, Tetsuichiro Muto, Kenichi Sugihara.   

Abstract

BACKGROUND: The clinicopathological features of ulcerative colitis-associated colorectal cancer (UC-CRC) have not yet been fully clarified, especially in Asian populations. This study aimed to clarify the prognosis and clinicopathological features of UC-CRC in comparison with sporadic CRC in the Japanese population.
METHODS: Histologically diagnosed UC-CRC patients between 1978 to 1998 were extracted from the Multi-Institutional Registry of Large-Bowel Cancer in Japan, a large nationwide CRC database, and the clinicopathological features and postoperative survival rates of UC-CRC patients and sporadic CRC patients were compared.
RESULTS: Among the 108,536 CRC patients registered between 1978 and 1998, a total of 169 UC-CRC patients were identified, including 121 patients who had been treated surgically. The proportion of UC-CRC patients increased in the period between 1995 and 1998 compared to that between 1978 and 1994. Comparisons with the sporadic CRC patients showed that the UC-CRC patients were younger, had a higher proportion of multiple cancer lesions, had higher proportions of superficial type lesions and invasive type lesions morphologically, and had higher proportions of mucinous or signet ring cell carcinomas. In stage III, UC-CRC patients had a poorer survival rate than the sporadic CRC patients (43.3% versus 57.4%, P = 0.0320).
CONCLUSIONS: UC-CRC increased over the investigated time periods and showed a poorer survival than sporadic CRC in the advanced stage, while no difference was observed in the early stage. By detecting UC-CRC at an early stage we can expect a similar postoperative outcomes to that of sporadic CRC. These results stress the importance of surveillance for the early detection of UC-CRC.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 20848547     DOI: 10.1002/ibd.21365

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  72 in total

1.  Epidermal growth factor receptor inhibits colitis-associated cancer in mice.

Authors:  Philip E Dubé; Fang Yan; Shivesh Punit; Nandini Girish; Steven J McElroy; M Kay Washington; D Brent Polk
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

Review 2.  Ulcerative colitis-associated colorectal cancer.

Authors:  Masakazu Yashiro
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

3.  Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits.

Authors:  Bianca W Chang; Aryavarta M S Kumar; Shlomo A Koyfman; Matthew Kalady; Ian Lavery; May Abdel-Wahab
Journal:  Int J Colorectal Dis       Date:  2015-01-08       Impact factor: 2.571

4.  Surgical outcomes of Korean ulcerative colitis patients with and without colitis-associated cancer.

Authors:  Yong Sik Yoon; Yong Beom Cho; Kyu Joo Park; Seung Hyuk Baik; Sang Nam Yoon; Seung-Bum Ryoo; Kil Yeon Lee; Hungdai Kim; Ryung-Ah Lee; Chang Sik Yu
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

5.  Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort.

Authors:  Hiroki Matsuoka; Hiroki Ikeuchi; Motoi Uchino; Toshihiro Bando; Yoshio Takesue; Takayuki Nishigami; Naohiro Tomita
Journal:  Int J Colorectal Dis       Date:  2012-10-19       Impact factor: 2.571

6.  Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.

Authors:  Bernhard W Renz; Wolfgang E Thasler; Gerhard Preissler; Tobias Heide; Philippe N Khalil; Michael Mikhailov; Karl-Walter Jauch; Martin E Kreis; Markus Rentsch; Axel Kleespies
Journal:  J Gastrointest Surg       Date:  2013-03-09       Impact factor: 3.452

Review 7.  A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.

Authors:  Ian S Reynolds; Aobhlinn O'Toole; Joseph Deasy; Deborah A McNamara; John P Burke
Journal:  Int J Colorectal Dis       Date:  2017-01-11       Impact factor: 2.571

8.  Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis.

Authors:  Baochi Ou; Jingkun Zhao; Shaopei Guan; Aiguo Lu
Journal:  Dig Dis Sci       Date:  2015-10-30       Impact factor: 3.199

Review 9.  Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.

Authors:  Elyse A Linson; Stephen B Hanauer
Journal:  Curr Gastroenterol Rep       Date:  2021-08-02

10.  In Vivo 19F MR Imaging Cell Tracking of Inflammatory Macrophages and Site-specific Development of Colitis-associated Dysplasia.

Authors:  Soo Hyun Shin; Deepak K Kadayakkara; Jeff W M Bulte
Journal:  Radiology       Date:  2016-07-19       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.